Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03128931 · ClinicalTrials.gov registry record · NA
SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation
A NA study, sponsored by Masimo Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT03128931: Clinical Trial NA study, sponsored by Masimo Corporation.
NCT03128931 is a NA study that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03128931, a NA study, was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of the study is to collect EEG data with the Masimo SedLine device along with vital signs, patient demographics, anesthetic record and surgical procedure during general anesthesia or sedation.
Primary Outcome
EEG signals will be collected using SedLine sensor for product development under different anesthesia and sedation conditions.
Interventions
- DEVICE Pediatric SedLine forehead EEG sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-12-23 |
| Est. Completion | 2018-11-29 |
| Phase | NA |
Why NCT03128931 stopped before completion
NCT03128931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Pediatric SedLine forehead EEG sensor is the first listed.
NCT03128931 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03128931 about?
NCT03128931 is a clinical study titled "SedLine Engineering Data Collection Study in Pediatric Patients Undergoing General Anesthesia or Sedation". The purpose of the study is to collect EEG data with the Masimo SedLine device along with vital signs, patient demographics, anesthetic record and surgical procedure during general anesthesia or sedation.
What is the current status of trial NCT03128931?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2016-12-23. Estimated completion is 2018-11-29.
What interventions are being tested in trial NCT03128931?
The interventions under investigation include: Pediatric SedLine forehead EEG sensor (DEVICE).
Who is sponsoring clinical trial NCT03128931?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03128931's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI